UCLA Division of Rheumatology is a clinical research site located in Los Angeles, California, United States 900095-1670.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Division of Rheumatology has participated in 8 clinical trials.
Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Systemic, Sclerosis, Systemic.
Sponsors: Amgen, Celgene, Targeted Genetics Corporation.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UCLA Division of Rheumatology has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Division of Rheumatology has 8 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Systemic, Sclerosis, Systemic.
Yes — UCLA Division of Rheumatology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.